Invention Grant
US08357782B2 Monoclonal antibodies specific for human interferon-alpha subtype alpha 8
失效
对人类干扰素α亚型alpha 8具有特异性的单克隆抗体
- Patent Title: Monoclonal antibodies specific for human interferon-alpha subtype alpha 8
- Patent Title (中): 对人类干扰素α亚型alpha 8具有特异性的单克隆抗体
-
Application No.: US12933768Application Date: 2009-03-16
-
Publication No.: US08357782B2Publication Date: 2013-01-22
- Inventor: Shigeharu Fukuda , Chie Ushio , Harumi Ariyasu , Tohru Kayano , Toshio Ariyasu , Tsunetaka Ohta
- Applicant: Shigeharu Fukuda , Chie Ushio , Harumi Ariyasu , Tohru Kayano , Toshio Ariyasu , Tsunetaka Ohta
- Applicant Address: JP Okayama
- Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
- Current Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
- Current Assignee Address: JP Okayama
- Agency: Browdy and Neimark, PLLC
- Priority: JP2008-072729 20080321; JP2008-149916 20080606
- International Application: PCT/JP2009/055039 WO 20090316
- International Announcement: WO2009/116491 WO 20090924
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; C12N5/12

Abstract:
The present invention has the first object to provide a monoclonal antibody specific to interferon α subtype α8 (IFNα8) and its mutant proteins, the second object to provide a hybridoma capable of producing the monoclonal antibody, the third object to provide a method for detecting the IFNα8 and its mutant proteins by the monoclonal antibody, the fourth object to provide a method for purifying the IFNα8 and its mutant proteins by the monoclonal antibody, and the fifth object to provide a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8. The present invention solves the above objects by providing a monoclonal antibody specific to IFNα8 and its mutant proteins, a hybridoma capable of producing the monoclonal antibody, a method for detecting the IFNα8 and its mutant proteins by immunoreaction using the monoclonal antibody, a method for purifying the IFNα8 and its mutant proteins using the monoclonal antibody, and a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8, which contains the monoclonal antibody as an effective ingredient.
Public/Granted literature
- US20110091968A1 MONOCLONAL ANTIBODY SPECIFIC TO BOTH HUMAN INTERFERON-ALPHA SUBTYPE ALPHA 8 AND ITS MUTANT PROTEINS Public/Granted day:2011-04-21
Information query